LakeShore Biopharma Co. L...
(LSB)
undefined
undefined%
At close: undefined
2.50
0.00%
After-hours Dec 13, 2024, 02:44 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -433.46M | -145.48M | -545.73K | -191.83M |
| Depreciation & Amortization | 42.19M | 36.69M | 31.15M | 27.91M |
| Stock-Based Compensation | 9.79M | 3.51M | 7.76M | 76.76M |
| Other Working Capital | 39.23M | -6.45M | -64.05K | -44.29K |
| Other Non-Cash Items | 153.78M | 4.42M | -3.45K | 2.23M |
| Deferred Income Tax | -21.73M | 1.13M | 4.94M | 17.45M |
| Change in Working Capital | -45.79M | -92.75M | -64.05K | -186.68M |
| Operating Cash Flow | -295.23M | -182.47M | -613.23K | -246.61M |
| Capital Expenditures | -44.25M | -57.05M | -298.93M | -104.88M |
| Acquisitions | - | - | - | - |
| Purchase of Investments | - | - | -200.00M | - |
| Sales Maturities Of Investments | - | - | - | - |
| Other Investing Acitivies | - | - | - | - |
| Investing Cash Flow | -44.25M | -56.98M | -200.00M | -104.24M |
| Debt Repayment | -78.93M | 100.88M | 364.56M | 8.26M |
| Common Stock Repurchased | - | - | - | - |
| Dividend Paid | - | - | - | - |
| Other Financial Acitivies | - | 216.57M | -163.06M | 729.41M |
| Financial Cash Flow | 205.26M | 317.45M | 201.50M | 739.26M |
| Net Cash Flow | -123.82M | 99.30M | -389.57M | 388.41M |
| Free Cash Flow | -339.48M | -239.52M | -299.55M | -351.49M |